English
 |
| Quantity: | |
|---|---|
XL-DS-KLDX
XINGLE
The Oral Liquid Large Dose Low Speed Vial Filling Production Line is designed for medium and large-scale pharmaceutical and nutraceutical manufacturers requiring accurate, hygienic, and reliable filling of large-dose oral liquid products.
Unlike high-speed systems typically used for small-volume filling, this production line adopts a controlled low-speed filling process to reduce splashing and foaming, improve dosing accuracy, and minimize product waste, making it especially suitable for large-volume or viscous liquid formulations.
Designed in compliance with GMP requirements, the line combines stable production capacity with operational flexibility. Its hygienic structure supports efficient cleaning, sterilization, and maintenance, helping reduce contamination risks and ensure consistent product quality.
With a focus on precision, stability, and compliance, the Oral Liquid Large Dose Low Speed Vial Filling Production Line provides a dependable solution for manufacturers seeking efficient and high-quality oral liquid production.
The Oral Liquid Large Dose Low Speed Vial Filling Production Line is engineered to deliver exceptional compatibility and operational adaptability for modern manufacturing facilities. Designed to efficiently process a wide range of liquid products, this integrated system seamlessly accommodates capacities between 30 and 500 ml. This broad volume range allows facilities to handle diverse product portfolios on a single line, adapting to various bottle sizes, shapes, and material specifications with minimal adjustment. By reducing the reliance on multiple dedicated machines, this production line significantly optimizes floor space, streamlines changeover procedures, and maximizes capital investment for pharmaceutical and health product manufacturers.
At the foundation of this oral liquid filling production line is a synchronized suite of four core equipment units. Each unit is engineered to perform critical stages of the manufacturing process with high precision, ensuring the integrity of the final liquid preparation:
Bottle Washing Machine: This initial unit ensures the thorough cleaning and preparation of vials, effectively removing particulates and preparing the containers for the subsequent sterilization process.
High-Temperature Tunnel Oven: Following the washing stage, this unit provides rigorous sterilization and depyrogenation. It ensures that all vials meet strict hygiene and safety standards before they enter the critical filling zone.
Filling Machine: Engineered for accuracy, this unit delivers precise volumetric dosing tailored to the 30 to 500 ml capacity range. It minimizes liquid product waste and ensures consistent, repeatable fill levels across every production batch.
Sealing/Capping Machine: The final core component securely seals the filled vials with reliable closures. This step is vital for protecting product integrity, preventing leaks, and avoiding contamination during downstream packaging, storage, and transport.
To address the dynamic needs of modern manufacturing, this production line features an innovative "linking line + stand-alone" dual-mode design. This structural flexibility allows facility managers to optimize their equipment utilization based on specific batch sizes and project requirements.
Linking Mode (Integrated Operation): This mode enables fully automated end-to-end operation, seamlessly connecting the workflow from initial bottle washing to final product sealing. It is specifically designed for continuous, high-efficiency production required in large-scale manufacturing. By operating as a unified, synchronized system, Linking Mode drastically reduces manual handling, mitigates the risk of cross-contamination, and maintains a steady, predictable output rate for commercial-scale demands.
Stand-Alone Mode (Independent Operation): For small-batch or customized production needs, each of the four core units can be decoupled and operated independently. This modular approach provides the crucial flexibility required to handle pilot runs, new product trials, and varied production scenarios without committing the entire line. Facilities can utilize individual machines for specific tasks, facilitating rapid changeovers, R&D testing, and specialized manufacturing runs while maximizing overall equipment effectiveness and reducing operational bottlenecks.
By integrating these two operational paradigms, the production line empowers manufacturers to seamlessly transition between high-volume commercial production and agile, small-scale development, ensuring long-term operational resilience and adapting to evolving market demands.
When investing in pharmaceutical processing equipment, measurable performance data is the most critical indicator of long-term value. This Oral Liquid Large Dose Low Speed Vial Filling Production Line is engineered to deliver industry-leading performance, meeting the stringent high standards required in both operational output and final product quality. By focusing on critical production metrics, this system directly addresses the core challenges of pharmaceutical manufacturing, helping facilities optimize their total cost of ownership, maintain strict regulatory compliance, and ensure a continuous, reliable product supply to the market. Below are the core data-driven advantages that make this production line a highly valuable asset for pharmaceutical facilities.
High Output with Consistent Operational Stability: Designed for continuous industrial applications, the line produces over 3,000 bottles per hour. This consistent capacity is specifically optimized to meet the high-volume production demands of medium-to-large pharmaceutical enterprises. By maintaining this steady output without frequent interruptions or mechanical bottlenecks, manufacturers can confidently schedule large batch runs, ensure a reliable product supply to the market, and significantly improve overall labor utilization. The stable operational rhythm also minimizes wear and tear on moving components, contributing to a longer equipment lifespan and predictable maintenance cycles.
Superior Quality Control & Production Efficiency: Achieving a first-pass yield is crucial for cost-effective manufacturing. This system operates with a product pass rate exceeding 99.5%, ensuring that the vast majority of processed vials move directly to the next process stage without requiring manual intervention. This exceptionally high qualification rate significantly reduces the need for rework, minimizes the waste of valuable liquid formulations, and shortens overall production time. For procurement managers, this translates to predictable production schedules, optimized resource allocation, and a higher overall equipment effectiveness (OEE) across the entire facility.
Low Breakage Rates & Enhanced Operational Safety: Handling glass containers safely is a primary concern in vial processing. Through optimized mechanical design and smooth transition mechanisms, the bottle breakage rate is strictly maintained below 0.5%. This remarkably low rate effectively cuts material loss costs associated with wasted glass and spilled pharmaceutical liquids. Furthermore, it significantly reduces the waste disposal burdens and prevents unexpected machine downtime typically caused by the need to clean up broken glass fragments on the production floor. The result is a safer, cleaner, and more continuous operating environment.
Precision Filling for Regulatory Compliance: Accuracy in liquid dosing is non-negotiable in the pharmaceutical sector. The filling accuracy of this production line strictly adheres to international pharmaceutical standards, with an error margin meticulously controlled within ±0.5% to 2%. This high level of precision ensures the exact required dosage per bottle, which is critical for patient safety and therapeutic efficacy. By preventing overfilling, manufacturers can save substantial costs on expensive active pharmaceutical ingredients (APIs), while preventing underfilling guarantees full compliance with stringent industry quality regulations and avoids costly batch rejections.
Reliable Sealing for Extended Product Shelf Life: The final integrity of the product depends heavily on the capping and sealing process. This equipment ensures that the stopper/seal integrity rate exceeds 99%, guaranteeing exceptionally tight sealing for every processed vial. This reliable closure system is essential to prevent liquid leakage during transport and storage, while also protecting the sensitive liquid formulations from external microbial contamination or oxidation. By maintaining consistent and secure seals, pharmaceutical manufacturers can confidently extend the shelf life of their products, ensure consistent clinical quality, and protect their brand reputation in the competitive healthcare market.
Ultimately, these core performance metrics demonstrate that this vial filling production line is a comprehensive solution designed to lower production risks and maximize operational efficiency. From precise dosing to reliable sealing, every data point reflects a commitment to supporting the rigorous demands of modern pharmaceutical manufacturing.
The Oral Liquid Large Dose Low Speed Vial Filling Production Line is engineered to meet the stringent demands of the modern pharmaceutical industry. Designed for versatility and operational reliability, this equipment provides a comprehensive solution for processing various liquid formulations. It is widely applicable to the production of oral liquid preparations, syrups, large-volume parenteral solutions, and various nutritional solutions. By accommodating different fluid characteristics and batch requirements, it supports pharmaceutical manufacturers in expanding their product portfolios while maintaining strict regulatory compliance.
Versatile Application Capabilities
Understanding the diverse needs of pharmaceutical processing, this production line is optimized for several key formulation types:
Oral liquid preparations: Ensuring precise dosing is critical for patient safety and therapeutic efficacy. The system handles oral liquids with consistent accuracy, making it suitable for a wide range of medical treatments and daily supplements.
Syrups: Syrups often present unique handling challenges due to their higher viscosity. The specialized filling mechanism is designed to manage these thicker liquids smoothly, preventing blockages and ensuring a clean, accurate fill without dripping or bottleneck contamination.
Large-volume parenteral solutions: For intravenous and parenteral applications, an aseptic environment is non-negotiable. The equipment supports rigorous sterilization protocols, maintaining the integrity of the solutions and safeguarding against airborne or mechanical contamination.
Nutritional solutions: Whether processing dietary supplements or specialized medical nutrition, the line handles sensitive ingredients carefully, preserving their stability and nutritional value throughout the entire packaging process.
Choosing our high-dose, low-speed oral liquid vial filling production line means choosing a strategic asset for your facility. Beyond simply processing liquids, it delivers measurable commercial advantages that directly impact your bottom line and operational stability:
1. End-to-end compliance assurance:
Navigating the complex landscape of pharmaceutical regulations requires equipment that inherently supports compliance. This production line establishes a strictly GMP-compliant aseptic filling environment, which significantly reduces compliance risks during regulatory audits. By minimizing human intervention and maintaining controlled environmental conditions, it protects product integrity from the first vial to the last. This end-to-end assurance helps pharmaceutical companies avoid costly batch rejections and protects their brand reputation in a highly regulated market.
2. Balanced productivity:
Modern pharmaceutical manufacturing requires agility. Facility managers often face the challenge of accommodating both large-scale commercial production and high-value-added, small-batch, personalized production. This equipment perfectly balances these competing needs. Its low-speed, high-precision design is ideal for processing specialized or high-value formulations where accuracy is prioritized over sheer volume. At the same time, its continuous operation capabilities ensure steady output for larger commercial runs, providing the flexibility needed to adapt to changing market demands without requiring multiple dedicated machines.
3. Extremely low total operating costs:
Capital investment in pharmaceutical equipment must be justified by long-term operational efficiency. This system is engineered to deliver extremely low total operating costs over its lifecycle. The gentle handling of vials results in a notably low bottle breakage rate, directly reducing packaging material waste and minimizing downtime caused by glass cleanup. Furthermore, high-precision filling eliminates product giveaway, which is particularly crucial when processing expensive active pharmaceutical ingredients. Combined with automated operation that significantly reduces manual labor requirements, these factors collectively drive down daily operational expenses and accelerate the return on investment.